Concepedia

David E. Lawhorn

DE

Statistics

Publications

3

Citations

141

H-Index

3

Active since

1990

Affiliations

Eli Lilly (United States)(Current)

David E. Lawhorn is an author at Eli Lilly (United States) specializing in molecular pharmacology, drug discovery, and pharmacotherapy.

Top concepts

Publications per year

1990–1993

3

Publications

3

Nonsteroidal inhibitors of human type I steroid 5-.alpha.-reductase

Charles D. Jones, James E. Audia, David E. Lawhorn et al. · Journal of Medicinal Chemistry · 1993 · 90 citations · Full text

, , +11

Response of 2-Lithio-4,5-dihydrofuran — Ketone Adducts to Acid Catalysis

Leo A. Paquette, David E. Lawhorn, Christopher A. Teleha · Heterocycles · 1990 · 26 citations · Full text

, , +9

Synthesis of the individual enantiomers of the benzoquinolinone human type 1 steroid 5-α-reductase inhibitors LY191704 and LY266111

James E. Audia, David E. Lawhorn, Jack B. Deeter · Tetrahedron Letters · 1993 · 25 citations

, , +10

1–3 of 3